NCT04612010

Brief Summary

This study will be recruiting individuals with Mal de Debarquement Syndrome (MdDS), a disorder caused by entrainment to oscillating motion that leads to persistent oscillating vertigo. The typical triggers for MdDS are sea and air travel. Prior studies on MdDS have shown that functional connectivity measured by both EEG and fMRI decreases when symptoms of MdDS improve. This study seeks to use asynchronous visual and auditory stimulation provided through a smart-phone app (WAVES) administered through virtual reality goggles to modulate the vertigo in MdDS with the hypothesis that these stimuli can desynchronize functional connectivity.

Trial Health

45
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
7mo left

Started Mar 2023

Longer than P75 for early_phase_1

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Mar 2023Dec 2026

First Submitted

Initial submission to the registry

October 26, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 2, 2020

Completed
2.3 years until next milestone

Study Start

First participant enrolled

March 1, 2023

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

May 9, 2023

Status Verified

May 1, 2023

Enrollment Period

3.8 years

First QC Date

October 26, 2020

Last Update Submit

May 7, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • MdDS Balance Rating Scale (MBRS)

    This is a 10 point self-reported scale that assesses the severity of rocking dizziness and its effect on balance function. The scale goes from 1 to 10 with 1 representing no feeling of motion and 10 representing motion severity so strong that standing is not possible.

    5 years

Secondary Outcomes (3)

  • Visual Analogue Scale

    5 years

  • Hospital Anxiety Depression Scale

    5 years

  • Dizziness Handicap Inventory

    5 years

Other Outcomes (1)

  • Electroencephalography (EEG)

    5 years

Study Arms (3)

Alpha frequency

ACTIVE COMPARATOR

Wobble oscillation will revolve the individual alpha frequency

Device: WAVES (Wobble-oscillator Auditory/Visual Excitatory Stimulation)

Alpha frequency plus

ACTIVE COMPARATOR

Wobble oscillation will revolve the individual alpha frequency plus 0.5Hz

Device: WAVES (Wobble-oscillator Auditory/Visual Excitatory Stimulation)

Theta frequency

SHAM COMPARATOR

Wobble oscillation will revolve the individual theta frequency

Device: WAVES (Wobble-oscillator Auditory/Visual Excitatory Stimulation)

Interventions

An app-based stimulation program administered that provides desynchronizing visual and auditory stimulation. The frequency of the stimulation oscillates around the baseline frequency determined by EEG.

Also known as: WAVES
Alpha frequencyAlpha frequency plusTheta frequency

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. Persistent oscillating vertigo that occurs within 48-hours of disembarking from a moving vessel such as a boat, car, or plane, 2. Symptoms improve with exposure to passive motion, 3. No other cause for symptoms after evaluation by a neurologist or otolaryngologist.

You may not qualify if:

  • \. History of epilepsy. 2. Structural brain injury such as stroke, brain tumor, or confluent white matter lesions. 3. Unstable medical or psychiatric condition. 4. Pregnant or planning to become pregnant during the study duration. 5. Not able to comply with all study procedures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Mal de debarquement

Study Officials

  • Yoon-Hee Cha, MD

    University of Minnesota

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Each arm involves real stimulation but only one is consistent with the hypothesis of desynchronization. The participant will not be aware of which administration is providing the target frequency of stimulation.
Purpose
DEVICE FEASIBILITY
Intervention Model
SEQUENTIAL
Model Details: The participants will be in an n-of-1 design with each participant receiving each frequency of stimulation in a randomized blinded order.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 26, 2020

First Posted

November 2, 2020

Study Start

March 1, 2023

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

May 9, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will share

Study protocol and de-identified data may be shared with through an institutional data sharing agreement.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
5 years
Access Criteria
Well-established or working under the supervision of a well-established researcher in the neurosciences with adequate justification for accessing the data under an appropriate data sharing agreement.